The interaction of age and hormone replacement therapy on colon adenoma risk

Cancer Detection and Prevention

Volumn 31, Issue 2, 2007, Pages 161-165

  Murff, Harvey J ^a,b   Shrubsole, Martha J ^a,b,c   Smalley, Walter E ^b,c   Wu, Huiyun ^c,d   Shyr, Yu ^c,d   Ness, Reid M ^b,c   Zheng, Wei ^a,b,c  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b DEPARTMENT OF VETERANS AFFAIRS   (United States)

^c VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^d VANDERBILT INGRAM CANCER CENTER   (United States)

Author keywords

Chemoprevention; Colon cancer; Hormone replacement therapy; Polyps

Indexed keywords

ESTROGEN;

ADULT; ARTICLE; CANCER RISK; CHEMOPROPHYLAXIS; COLON ADENOMA; COLONOSCOPY; COLORECTAL TUMOR; CONTROLLED STUDY; DEMOGRAPHY; DRUG USE; FEMALE; HORMONE SUBSTITUTION; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RACE DIFFERENCE;

ADENOMA; ADENOMATOUS POLYPS; ADULT; AGE FACTORS; AGED; CASE-CONTROL STUDIES; COLONIC NEOPLASMS; COLONIC POLYPS; COLONOSCOPY; FEMALE; HORMONE REPLACEMENT THERAPY; HUMANS; MIDDLE AGED; POSTMENOPAUSE; RISK FACTORS; TIME FACTORS;

EID: 34247595396     PISSN: 0361090X     EISSN: 15251500     Source Type: Journal    
DOI: 10.1016/j.cdp.2007.03.002     Document Type: Article

References (19)

1. Grodstein F., Newcomb P.A., and Stampfer M.J. Postmenopausal hormone therapy and the risk of colorectal cancer: a review and meta-analysis. Am J Med 106 5 (1999) 574-582
2. Nanda K., Bastian L.A., Hasselblad V., and Simel D.L. Hormone replacement therapy and the risk of colorectal cancer: a meta-analysis. Obstet Gynecol 93 5 Part 2 (1999) 880-888
3. Hebert-Croteau N. A meta-analysis of hormone replacement therapy and colon cancer in women. Cancer Epidemiol Biomarkers Prev 7 8 (1998) 653-659
4. Troisi R., Schairer C., Chow W.H., Schatzkin A., Brinton L.A., and Fraumeni Jr. J.F. A prospective study of menopausal hormones and risk of colorectal cancer (United States). Cancer Causes Control 8 2 (1997) 130-138
5. Kampman E., Potter J.D., Slattery M.L., Caan B.J., and Edwards S. Hormone replacement therapy, reproductive history, and colon cancer: a multicenter, case-control study in the United States. Cancer Causes Control 8 2 (1997) 146-158
6. Fernandez E., La Vecchia C., Braga C., Talamini R., Negri E., Parazzini F., et al. Hormone replacement therapy and risk of colon and rectal cancer. Cancer Epidemiol Biomarkers Prev 7 4 (1998) 329-333
7. Terry M.B., Neugut A.I., Bostick R.M., Sandler R.S., Haile R.W., Jacobson J.S., et al. Risk factors for advanced colorectal adenomas: a pooled analysis. Cancer Epidemiol Biomarkers Prev 11 7 (2002) 622-629
8. Purdue M.P., Mink P.J., Hartge P., Huang W.Y., Buys S., and Hayes R.B. Hormone replacement therapy, reproductive history, and colorectal adenomas: data from the prostate, lung colorectal and ovarian (PLCO) cancer screening trial (United States). Cancer Causes Control 16 8 (2005) 965-973
9. Prihartono N., Palmer J.R., Louik C., Shapiro S., and Rosenberg L. A case-control study of use of postmenopausal female hormone supplements in relation to the risk of large bowel cancer. Cancer Epidemiol Biomarkers Prev 9 4 (2000) 443-447
10. Jacobs E.J., White E., and Weiss N.S. Exogenous hormones, reproductive history, and colon cancer (Seattle, Washington, USA. Cancer Causes Control 5 4 (1994) 359-366
11. Newcomb P.A., and Storer B.E. Postmenopausal hormone use and risk of large-bowel cancer. J Natl Cancer Inst 87 14 (1995) 1067-1071
12. Woodson K., Lanza E., Tangrea J.A., Albert P.S., Slattery M., Pinsky J., et al. Hormone replacement therapy and colorectal adenoma recurrence among women in the polyp prevention trial. J Natl Cancer Inst 93 23 (2001) 1799-1805
13. Woodson K., Weisenberger D.J., Campan M., Laird P.W., Tangrea J., Johnson L.L., et al. Gene-specific methylation and subsequent risk of colorectal adenomas among participants of the polyp prevention trial. Cancer Epidemiol Biomarkers Prev 14 5 (2005) 1219-1223
14. Issa J.P., Ottaviano Y.L., Celano P., Hamilton S.R., Davidson N.E., and Baylin S.B. Methylation of the oestrogen receptor CpG island links ageing and neoplasia in human colon. Nat Genet 7 4 (1994) 536-540
15. Slattery M.L., Potter J.D., Curtin K., Edwards S., Ma K.N., Anderson K., et al. Estrogens reduce and withdrawal of estrogens increase risk of microsatellite instability-positive colon cancer. Cancer Res 61 1 (2001) 126-130
16. Peters U., Hayes R.B., Chatterjee N., Shao W., Schoen R.E., Pinsky P., et al. Circulating vitamin D metabolites, polymorphism in vitamin D receptor, and colorectal adenoma risk. Cancer Epidemiol Biomarkers Prev 13 4 (2004) 546-552
17. Bullamore J.R., Wilkinson R., Gallagher J.C., Nordin B.E., and Marshall D.H. Effect of age on calcium absorption. Lancet 2 7672 (1970) 535-537
18. Whelan R.L., Horvath K.D., Gleason N.R., Forde K.A., Treat M.D., Teitelbaum S.L., et al. Vitamin and calcium supplement use is associated with decreased adenoma recurrence in patients with a previous history of neoplasia. Dis Colon Rectum 42 2 (1999) 212-217
19. Baron J.A., Beach M., Mandel J.S., van Stolk R.U., Haile R.W., Sandler R.S., et al. Calcium supplements for the prevention of colorectal adenomas. Calcium polyp prevention study group. New Engl J Med 340 2 (1999) 101-107